OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$9.45 (−71.32%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Outset Medical, Inc. saw revenue fall 1.3% to $117.80M over the twelve months to Jun 30, 2026. Free cash flow was -$38.88M.
Revenue
$117.80M
-1.3% vs. a year earlier
Operating income
-$66.04M
TTM Q2 2026
Free cash flow
-$38.88M
TTM Q2 2026
EPS, diluted
-$5.37
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $70.75K
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- 0.00
- Dividend yield
- –
- Free cash flow yield
- -54950.94%
Fundamentals
- Revenue
- $117.80M
- Net income
- -$74.29M
- EPS, diluted
- -$5.37
- Free cash flow
- -$38.88M
- Book value per share
- $5174.12
- Diluted shares
- 0M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$117.80M-1.3% YoY
Gross profit
$49.20M+13.1% YoY
Operating income
-$66.04M
Net income
-$74.29M
EPS, diluted
–
Free cash flow
-$38.88M
Reported periodTrailing twelve months